Skip to main content

Sunshine Coast Health Launches First Local Corneal Crosslinking Service: An Australian First in Nurse-Led Ophthalmic Care

December 10, 2025

News from our associate member Sunshine Coast Health

In November 2025, the Sunshine Coast Health (SCH) Ophthalmology Department commenced its first corneal service for local patients. This new service focuses on treating keratoconus—a sight-threatening condition affecting approximately 1 in 84 Australians. Keratoconus is managed using a one-hour procedure known as corneal crosslinking, a highly effective treatment that can prevent the need for more complex interventions such as corneal grafting.

An Australian First in Nurse-Led Ophthalmology

This initiative represents Australia’s first nurse-led ophthalmology corneal crosslinking service. Previously, this procedure was performed solely by ophthalmic medical officers. SCH’s model follows in the footsteps of world-leading ophthalmic hospitals, including Moorfields Eye Hospital in London and the Royal Eye and Ear Hospital in Dublin.

Ophthalmology CNC team (from left to right) Ms Gillian Matthews, Ms Blessel Villa and Mr Mark Crocker 

Demonstration of a patient work up for Corneal crosslinking (left) Demonstration of a patient during corneal crosslinking procedure (Right) 

At the time of writing, Ophthalmology Clinical Nurse Consultants (CNCs) have completed five procedures under the supervision of Corneal Consultant Dr Nicholas York. By 2026, the CNC team will be fully credentialed to perform corneal crosslinking independently.

Improving Local Access to Specialist Care

Until now, Sunshine Coast patients requiring corneal procedures have needed to travel to Brisbane for treatment. The introduction of this corneal service marks the beginning of SCH’s broader plan to expand its ophthalmology offerings and provide more comprehensive care close to home.

This development also highlights the power of a multidisciplinary approach to healthcare. By enabling highly skilled nursing staff to lead this service, medical officers are freed to focus on more complex cases, ensuring timely and effective care for all patients.

Ophthalmology CNCs Mr Mark Crocker, Ms Gillian Matthews, and Ms Blessel Villa will manage patient consent, conduct pre-procedure information calls, perform the corneal crosslinking treatment, and complete the initial postoperative review four days after the procedure. Ophthalmology Pharmacist Ms Teisha Doherty will also play a vital role by providing essential post-procedure medication education, further supporting patient safety and treatment outcomes.

Acknowledgements

The CNC team extends its sincere thanks to Queensland Health’s Health Improvement Unit (HIU) for their invaluable support in sponsoring this project. Without their backing, this initiative would not have been possible.

Appreciation is also offered to the World Association of Eye Hospitals (WAEH) and Nurse Diana Malata for providing the inspiration that helped spark the development of this service.

The team additionally acknowledges former Director of Ophthalmology Dr David Squirrell for approving the creation of this nurse-led clinic and expresses deep gratitude to Dr Nicholas York for his guidance, belief, and commitment to supporting nurses to work at the top of their scope of practice.

Corneal Crosslinking team with Pharmacist Teisha Doherty and Corneal Specialist Consultant Dr Nicholas York. 

Older news


More recent

Glaucoma Insights course

News from our full member St. Erik Eye Hospital On 26 – 27 November, the St. Erik Eye Hospital is hosting the Glaucoma Insights Course in Stockholm. It is an intensive two-day course offering a rare opportunity to meet, learn from and discuss clinical challenges directly with seven internationally leading glaucoma experts. There are still […]

New Moorfields stem cell treatment improves vision for untreatable condition

News from our full member Moorfields Eye Hospital A new breakthrough stem cell treatment for ARK (aniridia-related keratopathy) has seen patients’ vision improve for this previously untreatable rare genetic eye condition in a first-in-human clinical trial at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, published in JAMA Ophthalmology. Aniridia is a surface disorder […]

Newsletter WAEH | May 2026

Join the WAEH 20th Annual Meeting! 🎉Our 20th Annual Meeting is coming up, and this year we are celebrating our Jubileum Year! This year the meeting will be in São Paulo (Brazil) from 9 – 13 November to share best practices in eye hospitals worldwide. There will also be facultative visits to Londrina (Brazil) and […]

Newsletter WAEH | April 2026

20th Annual Meeting: send in your proposals now! 🎉Our 20th Annual Meeting is coming up, and this year we are celebrating our Jubileum Year! This year the board meeting will be in São Paulo from 9-13 November to share best practices in eye hospitals worldwide. There will also be facultative visits to Londrina (Brazil) and […]

Newsletter WAEH | July

WAEH Community of Practice FAIR Images in Ophthalmology | 27 August 2026 FAIR data stands for Findable, Accessible, Interoperable, and Reusable. These are principles for managing, storing, and publishing research data in such a way that both humans and computers can easily find, understand, and reuse them, making scientific research more efficient and reliable. This […]